库博体育登不上

<thead id="dzhdl"></thead>
    <thead id="dzhdl"></thead>
    <sub id="dzhdl"></sub>

    <thead id="dzhdl"></thead>
    
    
    <form id="dzhdl"></form>
      <address id="dzhdl"></address>
          <sub id="dzhdl"></sub>
          <address id="dzhdl"></address>

                <address id="dzhdl"></address>
                <sub id="dzhdl"></sub>

                <sub id="dzhdl"></sub>
                <sub id="dzhdl"></sub>
                <sub id="dzhdl"></sub>
                <thead id="dzhdl"></thead>

                <address id="dzhdl"></address>

                  Guangming Online> World

                  Therapeutic trial results against COVID-19 expected in 3 weeks: WHO chief

                  SWITZERLAND-GENEVA-WHO-NCP-THERAPEUTIC TRIAL RESULTS

                  The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus (L) attends a daily briefing in Geneva, Switzerland, Feb. 20, 2020. WHO said Thursday that preliminary results from clinical trials of therapeutics against COVID-19 are expected in three weeks. (Xinhua/Chen Junxia)

                  GENEVA, Feb. 21 (Xinhua) -- The World Health Organization (WHO) said Thursday that preliminary results from clinical trials of therapeutics against COVID-19 are expected in three weeks.

                  "We're also looking forward to results from two clinical trials of therapeutics prioritized by the WHO R&D Blueprint," WHO Director-General Tedros Adhanom Ghebreyesus said at a daily briefing.

                  One of the trials he referred to is the combination of two drugs for HIV, lopinavir and ritonavir, while the other is testing an antiviral called remdesivir. "We expect preliminary results in three weeks," he added.

                  Remdesivir is a drug developed by U.S. pharmaceutical company Gilead Sciences. It has shown good antiviral activity against SARS and MERS coronavirus in previous cell and animal experiments.

                  It has also shown fairly good antiviral activity against the COVID-19 at the cellular level. A randomized, double-blind, placebo-controlled clinical trial of remdesivir started on Feb. 6 in several hospitals in the central Chinese city of Wuhan, and the trial will last until the end of April.

                  A study published in 2004 showed the anti-HIV drug combination of Lopinavir and Ritonavir has "substantial clinical benefit" when given to patients who had SARS. The Wuhan Jinyintan Hospital, where the first 41 known patients were treated, has already launched a randomized, controlled trial of the anti-HIV drug combination, according to a report by Chinese researchers in the Lancet medical journal late last month.

                  The third version of COVID-19 treatment guidelines published by China's National Health Commission suggested that taking two Lopinavir/Ritonavir pills and inhaling a dose of nebulized alpha-interferon twice a day could benefit patients.

                  [ Editor: SRQ ]
                  <thead id="dzhdl"></thead>
                    <thead id="dzhdl"></thead>
                    <sub id="dzhdl"></sub>

                    <thead id="dzhdl"></thead>
                    
                    
                    <form id="dzhdl"></form>
                      <address id="dzhdl"></address>
                          <sub id="dzhdl"></sub>
                          <address id="dzhdl"></address>

                                <address id="dzhdl"></address>
                                <sub id="dzhdl"></sub>

                                <sub id="dzhdl"></sub>
                                <sub id="dzhdl"></sub>
                                <sub id="dzhdl"></sub>
                                <thead id="dzhdl"></thead>

                                <address id="dzhdl"></address>

                                  澳门钻石娱乐网址

                                  买球竞猜网站-首页

                                  金龙彩票注册网站

                                  皇冠足球投注-现金

                                  球探比分即时足球比分

                                  d8的彩的正确网址

                                  大旺彩票登录

                                  亚洲城娱乐ca88试玩

                                  星力电玩城手机捕鱼

                                   

                                  澳门钻石娱乐网址

                                  买球竞猜网站-首页

                                  金龙彩票注册网站

                                  皇冠足球投注-现金

                                  球探比分即时足球比分

                                  d8的彩的正确网址

                                  大旺彩票登录

                                  亚洲城娱乐ca88试玩

                                  星力电玩城手机捕鱼